Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $2.14 million. The enterprise value is -$14.97 million.
| Market Cap | 2.14M |
| Enterprise Value | -14.97M |
Important Dates
The next estimated earnings date is Monday, April 7, 2025, after market close.
| Earnings Date | Apr 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GLMD has 1.51 million shares outstanding. The number of shares has increased by 136.81% in one year.
| Current Share Class | 1.51M |
| Shares Outstanding | 1.51M |
| Shares Change (YoY) | +136.81% |
| Shares Change (QoQ) | +58.13% |
| Owned by Insiders (%) | 1.19% |
| Owned by Institutions (%) | 3.08% |
| Float | 1.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/TBV Ratio | 0.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.03
| Current Ratio | 7.03 |
| Quick Ratio | 6.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.22% and return on invested capital (ROIC) is -24.96%.
| Return on Equity (ROE) | -37.22% |
| Return on Assets (ROA) | -21.98% |
| Return on Invested Capital (ROIC) | -24.96% |
| Return on Capital Employed (ROCE) | -36.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$790,500 |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.35% in the last 52 weeks. The beta is 0.67, so GLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -65.35% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 3.43 |
| Relative Strength Index (RSI) | 31.21 |
| Average Volume (20 Days) | 2,609,171 |
Short Selling Information
| Short Interest | 48,498 |
| Short Previous Month | 4,859 |
| Short % of Shares Out | 2.96% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.79M |
| Pretax Income | -6.36M |
| Net Income | -6.32M |
| EBITDA | -6.70M |
| EBIT | -6.79M |
| Earnings Per Share (EPS) | -$11.34 |
Balance Sheet
The company has $17.14 million in cash and n/a in debt, giving a net cash position of $17.14 million or $11.37 per share.
| Cash & Cash Equivalents | 17.14M |
| Total Debt | n/a |
| Net Cash | 17.14M |
| Net Cash Per Share | $11.37 |
| Equity (Book Value) | 18.44M |
| Book Value Per Share | 12.23 |
| Working Capital | 15.17M |
Cash Flow
| Operating Cash Flow | -4.81M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.81M |
| FCF Per Share | -$3.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -136.81% |
| Shareholder Yield | -136.81% |
| Earnings Yield | -291.42% |
| FCF Yield | -221.61% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |